Skip to main content
Livermore
Livermore
ZHEN

Iterum Therapeutics plc

ITRMDelisted Jun 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001659323

Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Iterum Therapeutics plc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
25
−14 vs. Q2 2022
Shares held
317.9K
−74.5K (−19.0%) vs. Q2 2022Converted for a 1-for-15 split
Total value
$575.4K
−$600.4K (−51.1%) vs. Q2 2022
New holders
2
8 more added
Sold out
16
8 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ITRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 25 institutions
Q1 2021: 50 institutionsQ2 2021: 45 institutionsQ3 2021: 42 institutionsQ4 2021: 45 institutionsQ1 2022: 41 institutionsQ2 2022: 39 institutionsQ3 2022: 25 institutionsQ4 2022: 23 institutionsQ1 2023: 17 institutionsQ2 2023: 17 institutionsQ3 2023: 15 institutionsQ4 2023: 16 institutionsQ1 2024: 18 institutionsQ2 2024: 15 institutionsQ3 2024: 18 institutionsQ4 2024: 24 institutionsQ1 2025: 20 institutionsQ2 2025: 24 institutionsQ3 2025: 24 institutionsQ4 2025: 20 institutionsQ1 2026: 18 institutionsQ2 2026: 2 institutions
Value heldQ3 2022: $575.4K
Q1 2021: $11.2MQ2 2021: $26.0MQ3 2021: $3.45MQ4 2021: $2.57MQ1 2022: $1.80MQ2 2022: $1.18MQ3 2022: $575.4KQ4 2022: $243.7KQ1 2023: $187.3KQ2 2023: $393.4KQ3 2023: $184.0KQ4 2023: $761.6KQ1 2024: $1.43MQ2 2024: $494.7KQ3 2024: $2.22MQ4 2024: $2.18MQ1 2025: $1.38MQ2 2025: $2.38MQ3 2025: $904.1KQ4 2025: $557.9KQ1 2026: $41.3KQ2 2026: $542
Institutions holding ITRM and their total value by quarter
QuarterHoldersValue
Q2 20262$542
Q1 202618$41.3K
Q4 202520$557.9K
Q3 202524$904.1K
Q2 202524$2.38M
Q1 202520$1.38M
Q4 202424$2.18M
Q3 202418$2.22M
Q2 202415$494.7K
Q1 202418$1.43M
Q4 202316$761.6K
Q3 202315$184.0K
Q2 202317$393.4K
Q1 202317$187.3K
Q4 202223$243.7K
Q3 202225$575.4K
Q2 202239$1.18M
Q1 202241$1.80M
Q4 202145$2.57M
Q3 202142$3.45M
Q2 202145$26.0M
Q1 202150$11.2M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Iterum Therapeutics plc; share changes are against Q2 2022.

Institutions holding ITRM in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
New Leaf Venture Partners, L.L.C.97,084$157.0K0.09%00.0%UnchangedConverted for a 1-for-15 split
Dimensional Fund Advisors LP62,301$101.0K0.00%+62,301New
IFP Advisors, Inc6,000$72.0K0.00%+5,600+1,400.0%AddedConverted for a 1-for-15 split
Renaissance Technologies LLC34,684$56.0K0.00%+13,131+60.9%AddedConverted for a 1-for-15 split
Jane Street Group, LLC30,479$49.0K0.00%+27,997+1,127.8%AddedConverted for a 1-for-15 split
Krilogy Financial LLC20,000$32.0K0.00%+6,667+50.0%AddedConverted for a 1-for-15 split
Franklin Resources Inc17,427$28.0K0.00%+175+1.0%AddedConverted for a 1-for-15 split
Grimes & Company, Inc.14,641$24.0K0.00%+2,681+22.4%AddedConverted for a 1-for-15 split
Morgan Stanley9,647$16.0K0.00%−5,100−34.6%ReducedConverted for a 1-for-15 split
UBS Group AG8,321$13.0K0.00%+8,321+12,481,400.0%AddedConverted for a 1-for-15 split
Focused Wealth Management, Inc6,999$11.0K0.00%00.0%UnchangedConverted for a 1-for-15 split
Edmond de Rothschild Holding S.A.6,666$11.0K0.00%00.0%UnchangedConverted for a 1-for-15 split
Creative Financial Designs Inc1,200$2.00K0.00%+667+125.0%AddedConverted for a 1-for-15 split
Tower Research Capital LLC (TRC)1,322$2.00K0.00%+1,322New
The PNC Financial Services Group, Inc.433$1.00K0.00%00.0%UnchangedConverted for a 1-for-15 split
American Portfolios Advisors133$2150.00%00.0%UnchangedConverted for a 1-for-15 split
Kelly Financial Services LLC120$1940.00%00.0%UnchangedConverted for a 1-for-15 split
Wells Fargo & Company305$00.00%00.0%UnchangedConverted for a 1-for-15 split
Howe & Rusling Inc33$00.00%−0−1.0%ReducedConverted for a 1-for-15 split
National Bank of Canada2$00.00%−0−16.7%ReducedConverted for a 1-for-15 split
HM Payson & Co3$00.00%−0−10.0%ReducedConverted for a 1-for-15 split
Ancora Advisors, LLC38$00.00%−1−1.4%ReducedConverted for a 1-for-15 split
Cypress Capital Management LLC (WY)66$00.00%−1−1.0%ReducedConverted for a 1-for-15 split
Advisor Group Holdings, Inc.12$00.00%−73−85.9%ReducedConverted for a 1-for-15 split
Larson Financial Group LLC13$00.00%−0−2.5%ReducedConverted for a 1-for-15 split
Canaan Partners X LLC0$00.00%−115,545−100.0%Sold outConverted for a 1-for-15 split
Goldman Sachs Group Inc0$00.00%−20,312−100.0%Sold outConverted for a 1-for-15 split
Gsa Capital Partners LLP0$00.00%−20,312−100.0%Sold outConverted for a 1-for-15 split
Verition Fund Management LLC0$00.00%−7,500−100.0%Sold outConverted for a 1-for-15 split
Virtu Financial LLC0$00.00%−7,365−100.0%Sold outConverted for a 1-for-15 split
Geode Capital Management, LLC0$00.00%−6,140−100.0%Sold outConverted for a 1-for-15 split
Millennium Management LLC0$00.00%−5,873−100.0%Sold outConverted for a 1-for-15 split
Brown Advisory Inc0$00.00%−4,000−100.0%Sold outConverted for a 1-for-15 split
Squarepoint Ops LLC0$00.00%−2,963−100.0%Sold outConverted for a 1-for-15 split
Citigroup Inc0$00.00%−2,667−100.0%Sold outConverted for a 1-for-15 split
Principle Wealth Partners LLC0$00.00%−2,000−100.0%Sold outConverted for a 1-for-15 split
Geneos Wealth Management Inc.0$00.00%−1,333−100.0%Sold outConverted for a 1-for-15 split
Savant Capital, LLC0$00.00%−926−100.0%Sold outConverted for a 1-for-15 split
Resources Investment Advisors, LLC.0$00.00%−1,104−100.0%Sold outConverted for a 1-for-15 split
Blue Bell Private Wealth Management, LLC0$00.00%−67−100.0%Sold outConverted for a 1-for-15 split
Captrust Financial Advisors0$00.00%−33−100.0%Sold outConverted for a 1-for-15 split